Non-muscle Invasive Bladder Cancer Market Set to Reach US$21.1 Billion by 2034, Driven by Rapid Advances in Immunotherapy and Targeted Treatments
The global market for Non-muscle Invasive Bladder Cancer (NMIBC) is witnessing significant transformation as advancements in oncology research, immunotherapy, and targeted treatment solutions continue to reshape therapeutic approaches. NMIBC represents a large proportion of bladder cancer diagnoses worldwide and typically involves tumors that have not penetrated the bladder muscle layer. Due to...
0 Commenti 0 Condivisioni 56 Visualizzazioni